Shugo Kowata

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Replacement Therapy

Hodgkin Lymphoma

Placebo Controlled

Top Venues

American journal of hematology

International journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Masataka Kuwana, Tomoki Ito, Shugo Kowata, Yoshihiro Hatta, Katsumichi Fujimaki, Kensuke Naito, Shingo Kurahashi, Toshiya Kagoo, Kazuki Tanimoto, So Saotome, Yoshiaki Tomiyama
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study. American journal of hematology (2024)
Masataka Kuwana, Tomoki Ito, Shugo Kowata, Yoshihiro Hatta, Katsumichi Fujimaki, Kensuke Naito, Shingo Kurahashi, Toshiya Kagoo, Kazuki Tanimoto, So Saotome, Yoshiaki Tomiyama
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study. American journal of hematology 99 (2) (2024)
Masataka Kuwana, Tomoki Ito, Shugo Kowata, Yoshihiro Hatta, Katsumichi Fujimaki, Kensuke Naito, Shingo Kurahashi, Toshiya Kagoo, Kazuki Tanimoto, So Saotome, Yoshiaki Tomiyama
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study. American journal of hematology 99 (2) (2024)
Masataka Kuwana, Tomoki Ito, Shugo Kowata, Yoshihiro Hatta, Katsumichi Fujimaki, Kensuke Naito, Shingo Kurahashi, Toshiya Kagoo, Kazuki Tanimoto, So Saotome, Yoshiaki Tomiyama
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study. American journal of hematology 99 (2) (2024)
Shugo Kowata, Yuki Seki, Yasuhiko Tsukushi, Tsuyoshi Sato, Kazuya Asano, Takahiro Maeta, Akiko Yashima-Abo, Ryosei Sasaki, Yoshiaki Okano, Tatsuo Oyake, Shigeki Ito
Association of CD8 + T cells expressing nivolumab-free PD-1 with clinical status in a patient with relapsed refractory classical Hodgkin lymphoma. International journal of hematology (2023)
Masataka Kuwana, Tomoki Ito, Shugo Kowata, Yoshihiro Hatta, Katsumichi Fujimaki, Kensuke Naito, Shingo Kurahashi, Toshiya Kagoo, Kazuki Tanimoto, So Saotome, Yoshiaki Tomiyama, null null
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group study. British journal of haematology (2022)